Brain-scan guided rTMS for treatment-resistant depression
Part of Mental health clinical trials.
This trial tests whether using brain-related “biomarkers” from your scans to guide rTMS can improve depression that hasn’t responded to at least one antidepressant. It may help by targeting brain circuits linked to depression more precisely.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 22 and 65 years old
- You have major depression confirmed by a study clinician
- Your depression is at least moderately severe (Hamilton score 18 or higher)
- In this current episode, at least one antidepressant at a proper dose and time did not help you
- You can safely have MRI scans
- You can give consent and allow the study team to talk with your own outpatient clinician
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether measuring your brain's electrical activity (EEG) during MRI can help personalize a type of brain stimulation treatment called TMS (transcranial magnetic stimulation) for people with hard-to-treat depression. The goal is to find early markers that predict who will respond to this treatment, so it can be tailored to each person for better results.
This trial tests an alternating combination of brain stimulation and brain imaging to see if it helps people with depression that hasn’t improved with usual treatments. The goal is to find a safer, more effective approach for people whose depression has been very difficult to treat.
This study is testing whether brain and heart signals can help predict who will respond to rTMS, a non-invasive treatment that uses magnetic pulses to stimulate parts of the brain. You would receive rTMS for depression and undergo MRI scans and heart monitoring to see if certain patterns predict improvement.
This study tests how a specific kind of brain stimulation (repetitive transcranial magnetic stimulation) works for people with depression that has not responded to standard treatments. If you qualify, it may help doctors understand the mechanism and improve options for treatment-resistant depression.
This trial studies signs in the brain (biomarkers) during an accelerated form of nerve stimulation to treat depression that hasn’t improved with usual antidepressants. It may help researchers learn who benefits and how to better personalize treatment.
This trial uses PET scans to see how transcranial magnetic stimulation (TMS) affects the brain in people whose depression hasn't improved with at least two different antidepressants. It aims to find markers that could predict who might benefit from TMS.
Hear when a new Treatment Resistant Depression trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.